According to XYZResearch,the global paclitaxel market was valued at 78.77 Million USD in 2017 and will reach 161.66 Million USD by the end of 2025, growing at a CAGR of 9.4% during 2019-2025.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".
Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The report is revolving around Paclitaxel active pharmaceutical ingredients.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 was about 31%, and the proportion was decreasing trend from 2012 to 2017.
Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel was sales in Ovarian Cancer, and the consumption proportion was about 46% in 2017.
North America was the largest consumption place, with a consumption market share nearly 53% in 2017. Europe was the second largest consumption place with the consumption market share of 19%, China was also an important sales region for the Paclitaxel.
Market competition is intense. Phyton, ScinoPharm, Novasep, Samyang, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
Geographically, global Paclitaxel market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Paclitaxel for each application, including
Ovarian Cancer
Cervical Cancer
Breast Cancer
Other
Production, consumption, revenue, market share and growth rate are the key targets for Paclitaxel from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Paclitaxel Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Paclitaxel Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Paclitaxel Market Performance
2.3 USA Paclitaxel Market Performance
2.4 Europe Paclitaxel Market Performance
2.5 Japan Paclitaxel Market Performance
2.6 Korea Paclitaxel Market Performance
2.7 India Paclitaxel Market Performance
2.8 Southeast Asia Paclitaxel Market Performance
2.9 South America Paclitaxel Market Performance
3 Global Paclitaxel Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Paclitaxel Market Performance (Volume)
3.3 USA Paclitaxel Market Performance (Volume)
3.4 Europe Paclitaxel Market Performance (Volume)
3.5 Japan Paclitaxel Market Performance (Volume)
3.6 Korea Paclitaxel Market Performance (Volume)
3.7 India Paclitaxel Market Performance (Volume)
3.8 Southeast Asia Paclitaxel Market Performance (Volume)
3.9 South America Paclitaxel Market Performance (Volume)
4 Competitive Analysis
4.1 Phyton
4.1.1 Phyton Profiles
4.1.2 Phyton Product Information
4.1.3 Phyton Paclitaxel Production, Revenue, Price and Gross Margin
4.1.4 Phyton Paclitaxel Business Performance
4.1.5 SWOT Analysis
4.2 ScinoPharm
4.2.1 ScinoPharm Profiles
4.2.2 ScinoPharm Product Information
4.2.3 ScinoPharm Paclitaxel Production, Revenue, Price and Gross Margin
4.2.4 ScinoPharm Paclitaxel Business Performance
4.2.5 SWOT Analysis
4.3 Novasep
4.3.1 Novasep Profiles
4.3.2 Novasep Product Information
4.3.3 Novasep Paclitaxel Production, Revenue, Price and Gross Margin
4.3.4 Novasep Paclitaxel Business Performance
4.3.5 SWOT Analysis
4.4 Samyang
4.4.1 Samyang Profiles
4.4.2 Samyang Product Information
4.4.3 Samyang Paclitaxel Production, Revenue, Price and Gross Margin
4.4.4 Samyang Paclitaxel Business Performance
4.4.5 SWOT Analysis
4.5 Polymed
4.5.1 Polymed Profiles
4.5.2 Polymed Product Information
4.5.3 Polymed Paclitaxel Production, Revenue, Price and Gross Margin
4.5.4 Polymed Paclitaxel Business Performance
4.5.5 SWOT Analysis
4.6 TAPI (Teva)
4.6.1 TAPI (Teva) Profiles
4.6.2 TAPI (Teva) Product Information
4.6.3 TAPI (Teva) Paclitaxel Production, Revenue, Price and Gross Margin
4.6.4 TAPI (Teva) Paclitaxel Business Performance
4.6.5 SWOT Analysis
4.7 Fresenius-kabi
4.7.1 Fresenius-kabi Profiles
4.7.2 Fresenius-kabi Product Information
4.7.3 Fresenius-kabi Paclitaxel Production, Revenue, Price and Gross Margin
4.7.4 Fresenius-kabi Paclitaxel Business Performance
4.7.5 SWOT Analysis
4.8 Huiang biopharma
4.8.1 Huiang biopharma Profiles
4.8.2 Huiang biopharma Product Information
4.8.3 Huiang biopharma Paclitaxel Production, Revenue, Price and Gross Margin
4.8.4 Huiang biopharma Paclitaxel Business Performance
4.8.5 SWOT Analysis
4.9 Southpharma
4.9.1 Southpharma Profiles
4.9.2 Southpharma Product Information
4.9.3 Southpharma Paclitaxel Production, Revenue, Price and Gross Margin
4.9.4 Southpharma Paclitaxel Business Performance
4.9.5 SWOT Analysis
4.10 Yunnan Hande
4.10.1 Yunnan Hande Profiles
4.10.2 Yunnan Hande Product Information
4.10.3 Yunnan Hande Paclitaxel Production, Revenue, Price and Gross Margin
4.10.4 Yunnan Hande Paclitaxel Business Performance
4.10.5 SWOT Analysis
4.11 Hainan Yew Pharm
4.12 Jiangsu Yew Biotechnology
5 Competitive Landscape
5.1 Global Paclitaxel Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Paclitaxel Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Paclitaxel Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Paclitaxel Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Paclitaxel Market Assessment by Regions
6.1 Global Paclitaxel Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Paclitaxel Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Paclitaxel Price (USD/Unit) by Regions (2014-2020)
6.4 Global Paclitaxel Gross Margin by Regions (2014-2020)
7 Paclitaxel Regional Analysis
7.1 China Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.2 USA Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.6 India Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Paclitaxel Production, Revenue and Growth Rate (2014-2020)
7.8 South America Paclitaxel Production, Revenue and Growth Rate (2014-2020)
8 Global Paclitaxel Consumption Assessment
8.1 Global Paclitaxel Consumption and Market Share by Regions (2014-2020)
8.2 Global Paclitaxel Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Paclitaxel Average Price (USD/Unit) by Regions (2014-2020)
9 Global Paclitaxel Sales Assessment by Regions
9.1 Global Paclitaxel Sales and Sales Value (2014-2020)
9.2 China Paclitaxel Sales and Sales Value (2014-2020)
9.3 USA Paclitaxel Sales and Sales Value (2014-2020)
9.4 Europe Paclitaxel Sales and Sales Value (2014-2020)
9.5 Japan Paclitaxel Sales and Sales Value (2014-2020)
9.6 Korea Paclitaxel Sales and Sales Value (2014-2020)
9.7 India Paclitaxel Sales and Sales Value (2014-2020)
9.8 Southeast Asia Paclitaxel Sales and Sales Value (2014-2020)
9.9 South America Paclitaxel Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2021-2026
12.1 Production and Revenue Forecast 2021-2026
12.1.1 Global Paclitaxel Production and Revenue by Regions 2021-2026
12.1.2 China Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.3 USA Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.4 Europe Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.5 Japan Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.6 Korea Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.7 India Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.8 Southeast Asia Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.1.9 South America Paclitaxel Production, Revenue and Growth Rate 2021-2026
12.2 Sales and Sales Value Forecast 2021-2026
12.2.1 Global Paclitaxel Consumption and Consumption Calue by Regions 2021-2026
12.2.2 Global Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.3 China Paclitaxel Sales, Sales Value and Growth Rate 2021-2026
12.2.4 USA Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.5 Europe Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.6 Japan Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.7 Korea Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.8 India Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.9 Southeast Asia Paclitaxel Sales and Sales Value Forecast 2021-2026
12.2.10 South America Paclitaxel Sales and Sales Value Forecast 2021-2026
12.3 Global Paclitaxel Production and Revenue Forecast by Type 2021-2026
12.3.1 Overall Market Performance
12.3.2 Natural Paclitaxel API
12.3.3 Semi-synthetic Paclitaxel API
12.4 Global Paclitaxel Sales Forecast by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 Ovarian Cancer
12.4.3 Cervical Cancer
12.4.4 Breast Cancer
12.4.5 Other
12.5 Global Paclitaxel Price and Gross Margin Forecast
13.5.1 Global Paclitaxel Averages Price Development Trend Forecast 2021-2026
13.5.2 Global Paclitaxel Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
The global Protein Bound Paclitaxel (Abraxane) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market ...
The global Liposomal Paclitaxel market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this...
The global Paclitaxel Drug market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...
The global Paclitaxel-eluting Stent market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...
The global Protein Bound Paclitaxel (Abraxane) market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market ...
The global Paclitaxel API market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field...
The global Paclitaxel market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field eva...
In the context of China-US trade war and COVID-19 epidemic, it will have a big influence on this market. Paclitaxel Injection Report by Material, Application, and Geography - Global Forecast to 2026 is a professional and comprehensive research report on the world's major regional market conditions, ...
Overview of the Global Paclitaxel Injection Market:The report discusses everything a marketer requires before investing in the global Paclitaxel Injection Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market s...
Overview of the Global Paclitaxel Injection Market:The report discusses everything a marketer requires before investing in the global Paclitaxel Injection Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market s...